GlassScriptPhysician profile
Meredith Lewis
NPI 1811553126
$1,180.27
in general payments reported to CMS, 2019-2025
14 companies · $669 in 2025
The $669 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.16 · 2023: $102 · 2024: $389 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,070 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.06 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $235.10 | 2024-2025 | |
| Novo Nordisk INC | $206.27 | 2023-2025 | Wegovy |
| Evofem Biosciences, INC. | $143.61 | 2023-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $140.54 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $93.37 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $62.79 | 2025 | |
| Organon LLC | $60.61 | 2022-2024 | |
| Shield Therapeutics INC | $54.28 | 2024 | |
| Abbvie INC. | $54.27 | 2023-2024 | |
| Pfizer INC. | $43.37 | 2023-2025 | |
| Exeltis, USA INC. | $34.00 | 2025 | Slynd |
| Dexcom, INC. | $24.81 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $15.82 | 2023 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $11.43 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.